The Double-edged Sword of Surgical Innovation: Ethical Issues of Early and Late Adoption of Novel Techniques
This activity has been archived and credit is no longer available.
In this presentation, Dr. Peter Angelos discusses innovation in surgery and the potential consequences of early versus late adoption of new techniques and technology. He provides insight on the role of professional ethics in responding to innovation and how to distinguish if cutting edge innovation is likely to be a relevant advance or not.
This Michael E. DeBakey Department of Surgery Grand Rounds session took place on Wednesday, April 7, 2021 at 7:00 A.M. and has been approved for Ethics Credit.
Activity Information
This activity has been archived and credit is no longer available.
Needs Statement
General, plastic, thoracic, vascular, cardiothoracic, abdominal transplantation and surgical oncology physicians, residents, fellows and medical students need to be regularly updated on novel therapies, as well as advances in surgical care and clinical practices that will aid them in treating a variety of surgical procedures to increase the patient care experience and improve practice efficiency.
Educational Objectives
At the conclusion of the session, the participants should be able to:
- Discuss the challenges of obtaining informed consent for novel operations.
- Assess the issues related to withholding surgical procedures that are proven to be effective.
- Distinguish the professional responsibilities surgeons have for managing innovative procedures and their impact on patients.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
Specialties
- Surgery
Interest Groups
- Hospital Medicine
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been designated by Baylor College of Medicine for 1 credit of education in medical ethics and/or professional responsibility.
Activity Director
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Term of Approval
April 1, 2021 through April 30, 2023. Original release date: April 1, 2021.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Peter Angelos, M.D., Ph.D., FACS
Linda Kohler Anderson Professor of Surgery
The University of Chicago Pritzker School of Medicine
Disclosure:
Nothing to disclose.
Activity Director
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Michele Loor, M.D., FACS
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Todd Rosengart, M.D., F.A.C.S.
DeBakey-Bard Chair of Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: